BOSTON SCIENTIFIC CORPORATION Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax
BOSTON SCIENTIFIC CORPORATION (BSX) reported Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax of -$3.00 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-01.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax · last filed 2018-05-01
- BOSTON SCIENTIFIC CORPORATION other comprehensive income (loss), reclassification adjustment from aoci on derivatives, tax for the quarter ending 2018-03-31 was -$3.00M.
- BOSTON SCIENTIFIC CORPORATION other comprehensive income (loss), reclassification adjustment from aoci on derivatives, tax for the quarter ending 2017-12-31 was $0.00.
- BOSTON SCIENTIFIC CORPORATION other comprehensive income (loss), reclassification adjustment from aoci on derivatives, tax for fiscal 2017 was $0.00.
- BOSTON SCIENTIFIC CORPORATION other comprehensive income (loss), reclassification adjustment from aoci on derivatives, tax for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- BOSTON SCIENTIFIC CORPORATION other comprehensive income (loss), reclassification adjustment from aoci on derivatives, tax for fiscal 2015 was $1.00M, a 97.37% decline from fiscal 2014.
- BOSTON SCIENTIFIC CORPORATION other comprehensive income (loss), reclassification adjustment from aoci on derivatives, tax for fiscal 2014 was $38.00M, a 171.43% increase from fiscal 2013.
| Period end | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax 3 month | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax 6 month | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax 9 month | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax 12 month | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax 12 month as first filed |
|---|---|---|---|---|---|
| 2018-03-31 | -$3.00M 10-Q · filed 2018-05-01 | -$3.00M derived: sum of 2 quarters · filed 2018-05-01 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-20 | $0.00 10-K · filed 2018-02-20 | |||
| 2017-09-30 | $0.00 10-Q · filed 2017-11-02 | ||||
| 2016-12-31 | $0.00 10-K · filed 2018-02-20 | $48.00M 10-K · filed 2017-02-23 | |||
| 2015-12-31 | $1.00M 10-K · filed 2018-02-20 | $78.00M 10-K · filed 2016-02-24 | |||
| 2014-12-31 | $38.00M 10-K · filed 2016-02-24 | ||||
| 2013-12-31 | $14.00M 10-K · filed 2015-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |